Clinical Trial: Safety and Efficacy of Venetoclax in Idiopathic Pulmonary Fibrosis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Idiopathic Pulmonary Fibrosis
Study Type: INTERVENTIONAL
Official Title: Safety and Efficacy of Venetoclax in Idiopathic Pulmonary Fibrosis
Brief Summary:
Based on preclinical data, investigators hypothesize that apoptosis resistance in monocyte-derived macrophages (MDMs) have a decisive role in the development of idiopathic pulmonary fibrosis (IPF).Specifically, macrophages from subjects with IPF have increased expression of Bcl-2 in mitochondria.In preclinical models of IPF, a conditional deletion of Bcl-2 in MDMs reverses established fibrosis by inducing apoptosis.Additional evidence to suggest that Bcl-2 expression in MDM mitochondria is a therapeutic target for…
Read more